Učitavanje...
Extracorporeal IgE Immunoadsorption in Allergic Asthma: Safety and Efficacy
BACKGROUND: Prevention of IgE-binding to cellular IgE-receptors by anti-IgE (Omalizumab) is clinically effective in allergic asthma, but limited by IgE threshold-levels. To overcome this limitation, we developed a single-use IgE immunoadsorber column (IgEnio). IgEnio is based on a recombinant, IgE-s...
Spremljeno u:
| Izdano u: | EBioMedicine |
|---|---|
| Glavni autori: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5360571/ https://ncbi.nlm.nih.gov/pubmed/28254561 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2017.02.007 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|